← The Wire
COAGNasdaq
Hemab Therapeutics Holdings, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 2114044
Develops and commercializes therapies for blood coagulation disorders, focusing on prophylactic treatments
red 8-K · 90d
$1.17B
Market cap
$36.73
Last close
+13.5%
1D
+15.7%
5D
362K
Volume
Price · last 39 sessions+44.9%
May 4L $24.98 · H $36.73Jun 29
9
Total filings
May 21, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 21, 20268-KResults of OperationsMay 21, 20268-KExecutive ChangeMay 11, 2026SC 13DSC 13DMay 11, 20268-KBylaw Amendment · Company UpdateMay 4, 2026424B4424B4May 1, 2026S-1/AS-1/AApr 30, 2026S-1/AS-1/AApr 28, 2026S-1/AS-1/AApr 27, 2026S-1S-1Apr 10, 2026
Similar companies
Comparable business profile · signals at a glance